GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sequent Scientific Ltd (BOM:512529) » Definitions » Equity-to-Asset

Sequent Scientific (BOM:512529) Equity-to-Asset : 0.44 (As of Sep. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Sequent Scientific Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sequent Scientific's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ₹6,796 Mil. Sequent Scientific's Total Assets for the quarter that ended in Sep. 2024 was ₹15,621 Mil. Therefore, Sequent Scientific's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.44.

The historical rank and industry rank for Sequent Scientific's Equity-to-Asset or its related term are showing as below:

BOM:512529' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.13   Med: 0.48   Max: 0.62
Current: 0.44

During the past 13 years, the highest Equity to Asset Ratio of Sequent Scientific was 0.62. The lowest was 0.13. And the median was 0.48.

BOM:512529's Equity-to-Asset is ranked worse than
71.21% of 1042 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs BOM:512529: 0.44

Sequent Scientific Equity-to-Asset Historical Data

The historical data trend for Sequent Scientific's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequent Scientific Equity-to-Asset Chart

Sequent Scientific Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.52 0.48 0.46 0.43

Sequent Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 - 0.43 - 0.44

Competitive Comparison of Sequent Scientific's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Sequent Scientific's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sequent Scientific's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sequent Scientific's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Sequent Scientific's Equity-to-Asset falls into.



Sequent Scientific Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Sequent Scientific's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=6565.6/15403.84
=0.43

Sequent Scientific's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=6795.8/15620.5
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sequent Scientific  (BOM:512529) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Sequent Scientific Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Sequent Scientific's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sequent Scientific Business Description

Traded in Other Exchanges
Address
Plot No. E7, Road No. 22, 301, 3rd Floor, Dosti Pinnacle, Wagle Industrial Estate, Thane (West), Mumbai, MH, IND, 400 604
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.

Sequent Scientific Headlines

No Headlines